EXamination of CArdiovascular OutcoMes with AlogliptIN versus Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome (EXAMINE)-Reference-Cited by-同舟云学术

EXamination of CArdiovascular OutcoMes with AlogliptIN versus Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome (EXAMINE)

Published:2011-10 Issue:4 Volume:162 Page:620-626.e1
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

White William B.,Bakris George L.,Bergenstal Richard M.,Cannon Christopher P.,Cushman William C.,Fleck Penny,Heller Simon,Mehta Cyrus,Nissen Steven E.,Perez Alfonso,Wilson Craig,Zannad Faiez

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference17 articles.

1. Epidemiology of cardiovascular complications in type 2 diabetes mellitus;Meigs;Acta Diabetol,2003

2. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007;Centers for Disease Control and Prevention (CDC),2008

3. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS-33);Lancet,1998

4. Long-term effects of intensive glucose lowering on cardiovascular outcomes;N Engl J Med,2011

5. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes;N Engl J Med,2008

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Modern Anti-Diabetic Treatment on Endothelial Progenitor Cells;Biomedicines;2023-11-14

2. Pathophysiological Sex Differences in Heart Failure Progression After Acute Coronary Syndrome: Insights From the EXAMINE Trial;Journal of Cardiac Failure;2023-11

3. Patient-centered medical home pharmacists’ impact on composite quality care measures for patients with uncontrolled type 2 diabetes;Journal of the American Pharmacists Association;2023-09

4. Commentary on cardiovascular safety of DPP4Is: Focus on Alogliptin;Indian Journal of Pharmacy and Pharmacology;2023-03-15

5. Safety and cardiometabolic efficacy of novel antidiabetic drugs;Expert Opinion on Drug Safety;2023-02-01